Urologix, which makes products to treat enlarged prostate, or benign prostatic hyperplasia, reported that its fiscal third-quarter revenue fell 17 percent because of “reduced order volume in direct, mobile and third-party mobile distribution channels.” The Plymouth, Minnesota-based company said that revenue was $2.98 million, down from $3.59 million a year ago. The loss widened to […]
The Plymouth-based company develops devices for treating enlarged prostate, or benign prostatic hyperplasia. Its Targis System uses microwave energy to heat and destroy enlarged prostate tissue as an alternative to pharmaceutical treatment. "The second quarter's results are disappointing and inconsistent with the efforts towards sustained, sequential revenue growth," CEO Stryker Warren Jr. said during the company's conference call.
This on-demand webinar will offer insights and share tips on helping practices run more efficiently.
Urologix Inc. (Nasdaq: ULGX) has hired a new chief financial officer who previously worked as a controller for device firm Angeion Corp. Brian Smrdel takes over the CFO role from Rebecca Weber, who will stay on as Urologix’s director of finance, according to a statement from the Minneapolis-based company. “In addition to his accounting experience […]
Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire […]